Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Lung Cancer | Correction

Correction to: The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer

Authors: Ping Zhao, Jun Wu, Feiteng Lu, Xuan Peng, Chenlin Liu, Nanjin Zhou, Muying Ying

Published in: BMC Cancer | Issue 1/2019

Login to get access

Excerpt

Correction to: Zhao et al. BMC Cancer (2019) 19:201. …
Literature
1.
Metadata
Title
Correction to: The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer
Authors
Ping Zhao
Jun Wu
Feiteng Lu
Xuan Peng
Chenlin Liu
Nanjin Zhou
Muying Ying
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5478-7

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue

Research article

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study

Research article

Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer

Research article

Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001–2011

Case report

Primary paediatric epidural sarcomas: molecular exploration of three cases

Research article

Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis

Research article

A nomogram for determining the disease-specific survival in Ewing sarcoma: a population study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits